S 1062
115th Congress
Senate
Health
Computers and information technology
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government buildings, facilities, and property
Government employee pay, benefits, personnel management
Government information and archives
Licensing and registrations
Performance measurement
Prescription drugs
Public contracts and procurement
Public participation and lobbying
User charges and fees
FDA Reporting Transparency and Accountability Act
Introduced: May 4, 2017
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 4, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 4, 2017
Introduced in Senate
Plain-English summary
FDA Reporting Transparency and Accountability Act
This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1